The increasing demand for POC tests (Point of Care Tests) for the diagnosis of Hospital Acquired Infections, also popularly called as HAIs will have a positive impact on the growth of the global healthcare-associated infectious disease diagnostics market during the forecast period.
A new report released is concerned about the diagnostics based on “Healthcare-associated Infectious Disease Diagnostics” which outlooks and forecasts about the Market segmentation in the upcoming part of the year. The molecular diagnostics have progressed to spread awareness in the end-users from research-based complex tests- or rather say that the citizens are getting aware of HAIs. While conventional techniques are being challenged, the development of molecular diagnostic tests includes high accuracy and specificity and multiple tests can be performed simultaneously. Molecular diagnostics will become a critical part of HAI testing, especially when it comes to combat against antibiotic resistance. The increasing penetration of POC tests for HAI Diagnostics and the increase In Target Patients with HAIs are likely to reinforce the rapidness of the growth in the diagnostics market.
Hence, the adoption of molecular diagnostics will probably increase at a significant rate due to its high sensitivity, specificity, and accuracy.
With the ability to deliver the results rapidly on the go. This adoption of molecular diagnostic testing will have a positive impact on the growth of the overall healthcare-associated infectious disease diagnostics market in the coming years. The study will compare the present scenario of the healthcare-associated infections diagnostics market and its market dynamics for the period 2018-2024.